These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2848164)
1. [Converting enzyme inhibitors in the treatment of chronic heart insufficiency: a meta-analysis of controlled clinical trials with placebo]. de Abajo FJ; Lopo CR Med Clin (Barc); 1988 Sep; 91(7):249-55. PubMed ID: 2848164 [No Abstract] [Full Text] [Related]
2. [Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors]. Schofer J Dtsch Med Wochenschr; 1988 Oct; 113(43):1684-9. PubMed ID: 2846252 [No Abstract] [Full Text] [Related]
3. Comparison of captopril and enalapril in patients with severe chronic heart failure. Packer M; Lee WH; Yushak M; Medina N N Engl J Med; 1986 Oct; 315(14):847-53. PubMed ID: 3018566 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
7. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians. Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of captopril with enalapril in the therapy of heart failure: effect on hemodynamics and kidney function]. Osterziel KJ; Dietz R; Mikulaschek K; Röhrig N; Schmid W; Manthey J; Kübler W Z Kardiol; 1988 Jun; 77(6):378-84. PubMed ID: 2850682 [TBL] [Abstract][Full Text] [Related]
9. Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management. Packer M; Kessler PD; Gottlieb SS Postgrad Med J; 1986; 62 Suppl 1():179-82. PubMed ID: 3022272 [TBL] [Abstract][Full Text] [Related]
10. [When and how to use angiotensin-converting enzyme inhibitors in heart failure]. Muiesan G; Alicandri C Cardiologia; 1987 Nov; 32(11):1227-30. PubMed ID: 2834058 [No Abstract] [Full Text] [Related]
11. [Current role of angiotensin II antagonists in the treatment of heart failure]. Porcu M; Orrù P Ital Heart J Suppl; 2000 Sep; 1(9):1213-4. PubMed ID: 11140296 [No Abstract] [Full Text] [Related]
12. Safety and efficacy of enalapril. Summing up the evidence. Dollery CT J Hypertens Suppl; 1983 Oct; 1(1):155-7. PubMed ID: 6100605 [No Abstract] [Full Text] [Related]
16. Angiotensin-converting-enzyme inhibitors in treatment of heart failure. Lancet; 1985 Oct; 2(8459):811-2. PubMed ID: 2864536 [No Abstract] [Full Text] [Related]
17. [Lisinopril in the treatment of heart insufficiency]. Barcina Sánchez C; Martín Cortés M; Fernández Fernández A An Med Interna; 1995 May; 12(5):246-53. PubMed ID: 7669880 [TBL] [Abstract][Full Text] [Related]
18. Enalapril: a second-generation angiotensin converting enzyme inhibitor. Bajaj AK Am J Med Sci; 1988 Nov; 296(5):332-5. PubMed ID: 2848421 [No Abstract] [Full Text] [Related]
19. Enalapril in chronic heart failure, a double-blind placebo-controlled study. Remes J; Nikander P; Rehnberg S; Halinen MO; Kuikka J; Länsimies E; Pyörälä K Ann Clin Res; 1986; 18(3):124-8. PubMed ID: 3017174 [TBL] [Abstract][Full Text] [Related]
20. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. Ettinger SJ; Benitz AM; Ericsson GF; Cifelli S; Jernigan AD; Longhofer SL; Trimboli W; Hanson PD J Am Vet Med Assoc; 1998 Dec; 213(11):1573-7. PubMed ID: 9838955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]